Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients

Haematologica

Volumn 86, Issue 5, 2001, Pages 504-509

  Vianelli, Nicola ^b   Valdrè, Lelia ^c   Fiacchini, Mauro ^c   De Vivo, Antonio ^a   Gugliotta, Luigi ^c   Catani, Lucia ^c   Lemoli, Roberto M ^c   Poli, Michela ^c   Tura, Sante ^c  

^a Arcispedale Santa Maria Nuova   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE

Author keywords

Elderly patients; Idiopathic thrombocytopenic purpura (ITP); Major bleeding; Severe symptomatic thrombocytopenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035348135     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th ed. Mc Graw Hill:New York; 1995.
2. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309-17.
3. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999; 94:909-13.
4. McMillan R. Chronic idiophatic thrombocytopenic purpura. N Engl J Med 1981; 304:1135-47.
5. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349:1531-6.
6. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
7. Schattner E, Bussel J. Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators. Am J Hematol 1994; 46:120-6.
8. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77:31-3.
9. Guthrie TH Jr, Brannan DP, Prisant LM. Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 1988; 296:17-21.
10. Vianelli N, Catani L, Gugliotta L, et al. Recombinant α-interferon 2b in the treatment of HIV-related thrombocytopenia. AIDS 1993; 7:823-7.
11. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338:1223-6.
12. Bussel J, Wissert M, Gates B, Scaramucci J, Nadeau K, Adelman B. Humanized monoclonal anti-CD40 ligand antibody (hu5c8) rescue therapy of 15 adults with severe chronic refractory ITP. Blood 1999; 94 (Suppl 1):646a.
13. Yang R, Han ZC. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update. Int J Hematol 2000; 71:18-24.
14. Mow BM, Hook CC. Rituximab for the treatment of refractory thrombocytopenic purpura. Case report. Blood 1999; 94(Suppl 1):82b.
15. Perotta AL, Abuel C. Update of response to rituximab of chronic relapsing ITP. Blood 1999; 94 (Suppl 1):82b.
16. Skoda RC, Tichelli A, Tyndall A, Hoffmann T, Gillessen S, Gratwohl A. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. Br J Haematol 1997; 99:56-7.
17. Lim SH, Kell J, al-Sabah A, Bashi W, Bailey-Wood R. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 349:475.
18. Lawrence JB, Yomtovian RA, Dillman C, et al. Reliability of automated platelet counts: comparison with manual method and utility for prediction of clinical bleeding. Am J Hematol 1995; 48:244-50.
19. Imbach P, Kuhne T. Immune thrombocytopenic purpura ITP. Vox Sang 1998; 74(Suppl 2):309-14.